Perseus Proteomics (TSE:4882) Common Stock: 円751.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4882 Perseus Proteomics Inc TSE:4882
57 GF Score
Price 円149.00
GF Value 円439.82
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Perseus Proteomics Common Stock?

Perseus Proteomics TSE:4882 -5.70% 57 Common Stock is 円751.2 Mil as of Mar. 2026. GuruFocus rates TSE:4882 with a GF Score™ of 57/100 and a GF Value™ of 円439.82 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Perseus Proteomics's quarterly common stock declined from Mar. 2025 (円2,437.9 Mil) to Sep. 2025 (円500.0 Mil) but then increased from Sep. 2025 (円500.0 Mil) to Mar. 2026 (円751.2 Mil).

Perseus Proteomics's annual common stock increased from Mar. 2024 (円1,971.0 Mil) to Mar. 2025 (円2,437.9 Mil) but then declined from Mar. 2025 (円2,437.9 Mil) to Mar. 2026 (円751.2 Mil).

Perseus Proteomics Common Stock Historical Data

* Premium members only.

The historical data trend for Perseus Proteomics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perseus Proteomics Common Stock Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only 1,939.25 1,939.25 1,971.02 2,437.91 751.16

Perseus Proteomics Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,971.02 2,436.15 2,437.91 500.00 751.16
TSE:4882
57GF Score
Perseus Proteomics Inc TSE:4882
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perseus Proteomics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of 円751.2 Mil mean?
Perseus Proteomics (TSE:4882) has a Common Stock of 円751.2 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Perseus Proteomics and its competitors.
Is Perseus Proteomics' Common Stock too high?
Perseus Proteomics' current Common Stock is 円751.2 Mil. Overall, Perseus Proteomics has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Perseus Proteomics' Common Stock compare to LLY and JNJ?
Perseus Proteomics' Common Stock of 円751.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Perseus Proteomics and its competitors. Perseus Proteomics's current Common Stock is 円751.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perseus Proteomics stock overvalued right now?
Based on GuruFocus' analysis, Perseus Proteomics (TSE:4882) is currently considered Significantly Undervalued. The stock's GF Value™ is 円439.82, compared to a current price of 円149.00 — trading 66.1% below its estimated fair value. The current Common Stock is 円751.2 Mil. Perseus Proteomics' overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Perseus Proteomics (TSE:4882), the current Common Stock is 円751.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perseus Proteomics (TSE:4882) Overvalued in 2026?

Based on GuruFocus' analysis, Perseus Proteomics stock appears to be undervalued. The current stock price of 円149.00 is trading 66.1% below its estimated GF Value™ of 円439.82. GuruFocus considers Perseus Proteomics to be Significantly Undervalued.

Key valuation signals for TSE:4882:

  • Common Stock: 円751.2 Mil
  • GF Value™: 円439.82 vs. price of 円149.00 (66.1% below fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the TSE:4882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perseus Proteomics Business Description

Address 30-1 Hakozakicho, Nihonbashi, Chuo-ku, AiNihombashi EAST 3rd floor, Tokyo, JPN, 103-0015
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody-based therapeutics and diagnostic drugs to cure cancer and other diseases. The Company operates in a single segment, the pharmaceutical business.
57GF Score

Get the complete analysis for TSE:4882

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円149.00
Price
円439.82
GF Value